Cargando…

Methods for analyzing cost effectiveness data from cluster randomized trials

BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmann, Max O, Fairall, Lara, Clark, Allan, Mugford, Miranda
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020454/
https://www.ncbi.nlm.nih.gov/pubmed/17822546
http://dx.doi.org/10.1186/1478-7547-5-12
_version_ 1782136598001876992
author Bachmann, Max O
Fairall, Lara
Clark, Allan
Mugford, Miranda
author_facet Bachmann, Max O
Fairall, Lara
Clark, Allan
Mugford, Miranda
author_sort Bachmann, Max O
collection PubMed
description BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Randomizing clusters instead of individuals tends to increase uncertainty but such data are often analysed incorrectly in published studies. METHODS: We used data from a cluster randomized trial to demonstrate five appropriate analytic methods: 1) joint modeling of costs and effects with two-stage non-parametric bootstrap sampling of clusters then individuals, 2) joint modeling of costs and effects with Bayesian hierarchical models and 3) linear regression of net benefits at different willingness to pay levels using a) least squares regression with Huber-White robust adjustment of errors, b) a least squares hierarchical model and c) a Bayesian hierarchical model. RESULTS: All five methods produced similar results, with greater uncertainty than if cluster randomization was not accounted for. CONCLUSION: Cost effectiveness analyses alongside cluster randomized trials need to account for study design. Several theoretically coherent methods can be implemented with common statistical software.
format Text
id pubmed-2020454
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20204542007-10-13 Methods for analyzing cost effectiveness data from cluster randomized trials Bachmann, Max O Fairall, Lara Clark, Allan Mugford, Miranda Cost Eff Resour Alloc Methodology BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Randomizing clusters instead of individuals tends to increase uncertainty but such data are often analysed incorrectly in published studies. METHODS: We used data from a cluster randomized trial to demonstrate five appropriate analytic methods: 1) joint modeling of costs and effects with two-stage non-parametric bootstrap sampling of clusters then individuals, 2) joint modeling of costs and effects with Bayesian hierarchical models and 3) linear regression of net benefits at different willingness to pay levels using a) least squares regression with Huber-White robust adjustment of errors, b) a least squares hierarchical model and c) a Bayesian hierarchical model. RESULTS: All five methods produced similar results, with greater uncertainty than if cluster randomization was not accounted for. CONCLUSION: Cost effectiveness analyses alongside cluster randomized trials need to account for study design. Several theoretically coherent methods can be implemented with common statistical software. BioMed Central 2007-09-06 /pmc/articles/PMC2020454/ /pubmed/17822546 http://dx.doi.org/10.1186/1478-7547-5-12 Text en Copyright © 2007 Bachmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Bachmann, Max O
Fairall, Lara
Clark, Allan
Mugford, Miranda
Methods for analyzing cost effectiveness data from cluster randomized trials
title Methods for analyzing cost effectiveness data from cluster randomized trials
title_full Methods for analyzing cost effectiveness data from cluster randomized trials
title_fullStr Methods for analyzing cost effectiveness data from cluster randomized trials
title_full_unstemmed Methods for analyzing cost effectiveness data from cluster randomized trials
title_short Methods for analyzing cost effectiveness data from cluster randomized trials
title_sort methods for analyzing cost effectiveness data from cluster randomized trials
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020454/
https://www.ncbi.nlm.nih.gov/pubmed/17822546
http://dx.doi.org/10.1186/1478-7547-5-12
work_keys_str_mv AT bachmannmaxo methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials
AT fairalllara methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials
AT clarkallan methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials
AT mugfordmiranda methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials